NB
Norinchukin Bank Portfolio holdings
AUM
$6.72B
1-Year Return
19.37%
This Quarter Return
-4.72%
1 Year Return
+19.37%
3 Year Return
+81.53%
5 Year Return
+130.2%
10 Year Return
+300.21%
AUM
$7.5B
AUM Growth
-$422M
(-5.3%)
Cap. Flow
+$39.1M
Cap. Flow
% of AUM
0.52%
Top 10 Holdings %
Top 10 Hldgs %
46.91%
Holding
559
New
9
Increased
517
Reduced
22
Closed
7
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$34.4M |
| 2 |
Invesco QQQ Trust
QQQ
|
$22.5M |
| 3 |
Apple
AAPL
|
$20.3M |
| 4 |
Microsoft
MSFT
|
$17.5M |
| 5 |
Copart
CPRT
|
$12.1M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$266M |
| 2 |
Colgate-Palmolive
CL
|
$19.6M |
| 3 |
3M
MMM
|
$15.6M |
| 4 |
McCormick & Company Non-Voting
MKC
|
$12.3M |
| 5 |
Church & Dwight Co
CHD
|
$8.27M |
Sector Composition
| 1 | Technology | 16.46% |
| 2 | Healthcare | 8.88% |
| 3 | Consumer Discretionary | 7.69% |
| 4 | Industrials | 6.67% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Charter Communications
CHTR
$35.7B
| $7.28M | 0.1% |
13,340
+988
| +8% | +$539K |
|
127
Cigna
CI
$81.5B
| $7.21M | 0.1% |
30,074
+1,572
| +6% | +$377K |
|
128
Public Storage
PSA
$52.2B
| $7.05M | 0.09% |
18,067
+1,436
| +9% | +$560K |
|
129
Becton Dickinson
BDX
$55.1B
| $7.02M | 0.09% |
27,046
+1,798
| +7% | +$467K |
|
130
Southern Company
SO
$101B
| $6.93M | 0.09% |
95,512
+6,475
| +7% | +$470K |
|
131
Vertex Pharmaceuticals
VRTX
$102B
| $6.88M | 0.09% |
26,357
+2,482
| +10% | +$648K |
|
132
Edwards Lifesciences
EW
$47.5B
| $6.82M | 0.09% |
57,917
+4,344
| +8% | +$511K |
|
133
Freeport-McMoran
FCX
$66.5B
| $6.8M | 0.09% |
136,660
+11,879
| +10% | +$591K |
|
|
ATVI
134
DELISTED
Activision Blizzard Inc.
ATVI
| $6.62M | 0.09% |
82,689
+8,256
| +11% | +$661K |
|
135
EOG Resources
EOG
$64.4B
| $6.54M | 0.09% |
54,807
+4,203
| +8% | +$501K |
|
136
Dominion Energy
D
$49.7B
| $6.44M | 0.09% |
75,812
+5,941
| +9% | +$505K |
|
137
Travelers Companies
TRV
$62B
| $6.29M | 0.08% |
34,422
+433
| +1% | +$79.1K |
|
138
Moderna
MRNA
$9.78B
| $6.28M | 0.08% |
36,443
+3,697
| +11% | +$637K |
|
139
Fiserv
FI
$73.4B
| $6.28M | 0.08% |
61,897
+5,757
| +10% | +$584K |
|
140
Idexx Laboratories
IDXX
$51.4B
| $6.25M | 0.08% |
11,425
+3,453
| +43% | +$1.89M |
|
141
Norfolk Southern
NSC
$62.3B
| $6.23M | 0.08% |
21,835
+1,095
| +5% | +$312K |
|
142
Ford
F
$46.7B
| $6.16M | 0.08% |
364,303
+28,646
| +9% | +$484K |
|
143
Cintas
CTAS
$82.4B
| $6.13M | 0.08% |
57,644
-4,120
| -7% | -$438K |
|
144
Northrop Grumman
NOC
$83.2B
| $6.11M | 0.08% |
13,663
+808
| +6% | +$361K |
|
145
Synopsys
SNPS
$111B
| $6.04M | 0.08% |
18,112
+2,886
| +19% | +$962K |
|
146
Newmont
NEM
$83.7B
| $5.98M | 0.08% |
75,233
+6,793
| +10% | +$540K |
|
147
Estee Lauder
EL
$32.1B
| $5.96M | 0.08% |
21,873
+1,862
| +9% | +$507K |
|
|
148
Colgate-Palmolive
CL
$68.8B
| $5.91M | 0.08% |
77,923
-258,118
| -77% | -$19.6M |
|
149
General Motors
GM
$55.5B
| $5.89M | 0.08% |
134,560
+10,854
| +9% | +$475K |
|
150
Boston Scientific
BSX
$159B
| $5.86M | 0.08% |
132,211
+10,089
| +8% | +$447K |
|